What is the ticker symbol for Century Therapeutics?

Century Therapeutics trades under the ticker IPSC on NASDAQ.

What sector does Century Therapeutics operate in?

Century Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze IPSC in a portfolio?

PortView shows IPSC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Century Therapeutics (IPSC) Stock Analysis

NASDAQHealthcareBiotechnology

$2.07+1.72%

1-year price historyRange $0.46 – $2.94

52-week range$2.07

$0.44$3.04

What Century Therapeutics does

Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's foremost clinical program is CNTY-101, an allogeneic, induced pluripotent stem cell (iPSC)-derived CAR-iNK cell therapy. This therapy is specifically designed to target CD19 in patients with B-cell lymphoma that has relapsed or proven refractory to previous treatments. In addition to its lead candidate, the company's robust pipeline features several other therapeutic assets: CNTY-103: A CAR-iNK candidate aimed at CD133 + EGFR for recurrent glioblastoma. CNTY-102: A CAR-iT therapy targeting CD19 + CD79b, intended for relapsed or refractory B-cell lymphoma and other B-cell cancers. CNTY-104: A multi-specific CAR-iT or CAR-iNK candidate in development for acute myeloid leukemia. CNTY-106: Another multi-specific CAR-iNK or CAR-iT candidate for multiple myeloma. Established in 2018, Century Therapeutics, Inc. is based in Philadelphia, Pennsylvania.

Key metrics

Market cap

$178.77M

P/E (TTM)

-1.95

EPS (TTM)

$-1.06

Beta

1.60

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$2.15

200-day avg

$1.92

52-week high

$3.04

52-week low

$0.44

CEO

Brent Pfeiffenberger

ETFs linked to IPSC

Broad-market and Healthcare sector ETFs an investor holding Century Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how IPSC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze IPSC in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Century Therapeutics?: Century Therapeutics trades under the ticker IPSC on NASDAQ.
Which exchange is IPSC listed on?: IPSC is listed on NASDAQ.
What sector does Century Therapeutics operate in?: Century Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze IPSC in a portfolio?: PortView shows IPSC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.